Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Deep Immunoprofiling By Flow Cytometry and NGS Reveals Distinct T Cell Profile in Pediatric Hepatitis-Associated Aplastic Anemia

Michaela Novakova, Michael Svaton, MD, Martina Sukova, MD, Veronika Kanderova, MSc, PhD, Nikos Darzentas, PhD, Lenka Kramna, MSc, PhD, Ondrej Cinek, Prof., MD PhD, Dagmar Pospisilova, Prof MD PhD, Jan Trka, Prof., MD PhD, Ondrej Hrusak, MD PhD, Jan Stary, Prof., MD PhD, Ester Mejstrikova, MD PhD, Eva Fronkova, MD PhD

Blood (2019) 134 (Supplement_1): 2508.

https://doi.org/10.1182/blood-2019-127986

Published: 2019

Journal Articles

Co-Targeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Refractory Mantle Cell Lymphoma with Complex Karyotype Changes

Pavel Klener, Jr., Marek Trněný, Ladislav Andera, MSc, PhD, Zuzana Nahacka, MSc, Magdalena Klanova, MD PhD, Jana Karolova, MD, Michael Svaton, MD, Ondrej Havranek, MDPhD, Jan Soukup, MD, Zuzana Zemanova, PhD, Diana Tuskova, MD, Eva Pokorna, Kristina Forsterova, MSc, PhD, Petra Vockova, MD, Eva Fronkova, MD PhD, Dana Prukova, Ing, PhD

Blood (2018) 132 (Supplement 1): 42.

https://doi.org/10.1182/blood-2018-99-112437

Published: 2018

Journal Articles

B Cell Precursor Lymphoblastic Leukemia Patients with Good Treatment Response Have Low Levels of Erythroid Precursors

Barbora Vakrmanova, MD, Michaela Novakova, Martina Vaskova, Iveta Janotová, Elena Vodickova, MD, Monika Brüggemann, Eva Fronkova, MD PhD, Jan Trka, MD PhD, Jan Stary, MD PhD, Ondrej Hrusak, Ester Mejstrikova, MD PhD

Blood (2018) 132 (Supplement 1): 2832.

https://doi.org/10.1182/blood-2018-99-117976

Published: 2018

Journal Articles

Switching Towards Monocytic Lineage and Discordancy between Flow Cytometric and PCR Minimal Residual Disease Results Is a Hallmark Feature of DUX4 Rearranged B-Cell Precursor Acute Lymphoblastic Leukemia

Michaela Novakova, Barbora Vakrmanova, MD, Lucie Slamova, Alena Musilova, Monika Brüggemann, Matthias Ritgen, MD, Eva Fronkova, MD PhD, Tomas Kalina, MD PhD, Jan Trka, MD PhD, Jan Stary, MD PhD, Martina Vaskova, Lucie Winkowska, Marketa Zaliova, Karel Fišer, PhD, Ondrej Hrusak, Ester Mejstrikova, MD PhD

Blood (2018) 132 (Supplement 1): 2825.

https://doi.org/10.1182/blood-2018-99-116575

Published: 2018

Journal Articles

Folate-Dependent Normocytic Anemia Caused By a Hypomorphic Mutation in SLC19A1 gene

Michael Svaton, MD, Karolina Skvarova Kramarzova, MSc, PhD, Veronika Kanderova, MSc, PhD, Petr Smisek, MD, Pavel Jesina, MSc, MD, PhD, Jakub Krijt, MSc, Blanka Stiburkova, MSc, PhD, Andrea Mancikova, MSc, Robert Dobrovolny, MSc, PhD, Violeta Bakardjieva-Mihaylova, MSc, Elena Vodickova, MD, Jan Stuchly, MSc, Tomas Kalina, MD PhD, Jan Stary, MD PhD, Jan Trka, MD PhD, Eva Fronkova, MD PhD, Viktor Kozich, MD PhD

Blood (2018) 132 (Supplement 1): 502.

https://doi.org/10.1182/blood-2018-99-113501

Published: 2018

Journal Articles

Observational Study Alternating R-CHOP21 and R-Cytarabine (3+3 Cycles) for Patients with Newly Diagnosed Mantle Cell Lymphoma Not Eligible for High-Dose Therapy: A Czech Lymphoma Study Group Trial Preliminary Results

Pavel Klener, MD, PhD, Eva Fronkova, MD, PhD, Robert Pytlik, MD, PhD, Marketa Kalinova, D.Sc., PhD, Kristina Forsterova, D.Sc., PhD, David Belada, MD, Martin Simkovic, MD, David Salek, MD, PhD, Heidi Mocikova, MD, PhD, Vit Prochazka, MD, PhD, Vit Campr, MD, PhD, Radek Jaksa, MD, Jozef Kubinyi, MD, PhD, Jiri Dolezal, MD, PhD, Ass.Prof., Jan Trka, MD, PhD, Prof., Marek Trneny, MD, PhD, Prof.

Blood (2014) 124 (21): 1720.

https://doi.org/10.1182/blood.V124.21.1720.1720

Published: 2014

Journal Articles

Next Generation Amplicon Sequencing of Immunoglobulin Heavy Chain Gene Rearrangaments for Minimal Residual Disease (MRD) Stratification in Childhood Acute Lymphoblastic Leukemia (ALL): A Comparison with Classical qPCR-Based Technique

Michaela Kotrova, MD, Katerina Muzikova, M.Sc., Ester Mejstrikova, MD, PhD, Michaela Novakova, Violeta Bakardjieva-Mihaylova, M.Sc., Fiser Karel, PhD, Jan Stuchly, M.Sc., Christiane Pott, M..D, PhD, Monika Bruggemann, MD, PhD, Stary Jan, MD, D.Sc., Prof., Jan Trka, MD, PhD, Prof., Eva Fronkova, MD, PhD

Blood (2014) 124 (21): 2395.

https://doi.org/10.1182/blood.V124.21.2395.2395

Published: 2014

Journal Articles

Potential Involvement of Physiological TCR Gamma Delta Clones in Immune Surveillance of Preleukemic Cells

Olga Zimmermannova, Marketa Zaliova, Anthony V. Moorman, Eva Fronkova, MD, PhD, Jan Stary, Jan Trka, Tomas Kalina, Jan Zuna

Blood (2014) 124 (21): 3775.

https://doi.org/10.1182/blood.V124.21.3775.3775

Published: 2014

Journal Articles

Refinement of IKZF1 Genomic Status in Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Tobia Lana, Paola de Lorenzo, Silvia Bresolin, PhD, Ilaria Bronzini, Monique L. Den Boer, MSc, PhD, Helene Cave, PhD, Eva Fronkova, MD, PhD, Martin Stanulla, MD, Marketa Zaliova, Christine J. Harrison, Hester de Groot-Kruseman, Claire Schwab, Maria Grazia Valsecchi, Andrea Biondi, Giuseppe Basso, MD, Giovanni Cazzaniga, PhD, Geertruy te Kronnie

Blood (2014) 124 (21): 3785.

https://doi.org/10.1182/blood.V124.21.3785.3785

Published: 2014

Journal Articles

Prediction of Relapse By microRNA Expression in Pediatric B-Lineage Acute Lymphoblastic Leukemia

Blood (2014) 124 (21): 3793.

https://doi.org/10.1182/blood.V124.21.3793.3793

Published: 2014

Journal Articles

Prognostic Value of Rare IKZF1 deletions in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia: An International Collaborative Study

Blood (2014) 124 (21): 368.

https://doi.org/10.1182/blood.V124.21.368.368

Published: 2014

Journal Articles

Prognostic Impact of Ikaros (IKZF1) Gene Alterations In Childhood ALL Treated with ALL IC-BFM 2002 Protocol: A Comparison of Gene Expression and Genomic-Based Methods.

Jana Volejnikova, MD, Ester Mejstrikova, MD, PhD, Karel Svojgr, MD, Jan Stary, MD, PhD, Jan Trka, MD, PhD, Eva Fronkova, MD, PhD

Blood (2010) 116 (21): 1656.

https://doi.org/10.1182/blood.V116.21.1656.1656

Published: 2010

Journal Articles

B Precursor ALL Subset with Aberrant CD2 Expression and a Specific Predisposition to Early Monocytic Transdifferentiation

Ester Mejstrikova, MD, PhD, Lucie Slamova, MD, Eva Fronkova, MD, PhD, Jan Zuna, MD, PhD, Jean-Pierre Bourquin, MD, PhD, Elena Vodickova, MD, Katerina Muzikova, Zuzana Zemanova, PhD, Vendula Pelkova, Frederik Van Delft, PhD, Tomas Kalina, MD, PhD, Karel Fiser, PhD, Petr Smisek, MD, Jan Trka, MD, PhD, Jan Stary, MD, DrSc, Ondrej Hrusak, MD, PhD

Blood (2010) 116 (21): 1708.

https://doi.org/10.1182/blood.V116.21.1708.1708

Published: 2010

Journal Articles

Relative Expression of Ikaros Isoforms Has a Prognostic Impact in Phildelphia-Negative Childhood Acute Lymphoblastic Leukemia.

Jana Volejnikova, MD, Ester Mejstrikova, MD, Jan Stary, Jan Trka, Eva Fronkova, MD, PhD

Blood (2009) 114 (22): 1282.

https://doi.org/10.1182/blood.V114.22.1282.1282

Published: 2009

Journal Articles

Prognostic Impact of Peripheral Blood Involvement during Early Time Points of Childhood ALL Treatment.

Jana Volejnikova, MD, Eva Fronkova, MD, PhD, Ester Mejstrikova, MD, Katerina Muzikova, Leona Reznickova, Dagmar Pospisilova, MD, Jaroslav Sterba, MD, PhD, Yahia Jabali, MD, Daniela Prochazkova, MD, Bohumir Blazek, MD, Jiri Hak, MD, Zdenka Cerna, MD, Jan Stary, MD, PhD, Jan Trka, MD, PhD

Blood (2008) 112 (11): 1489.

https://doi.org/10.1182/blood.V112.11.1489.1489

Published: 2008

Journal Articles

CD44 and CD27 Expression Delineates Stages of B Precursor Development Reflecting Recombination Status and Propensity to Leukemic Transformation.

Martina Vaskova, Eva Fronkova, MD,PhD, Julia Starkova, Tomas Kalina, MD,PhD, Ester Mejstrikova, MD, Ondrej Hrusak, MD,PhD

Blood (2006) 108 (11): 1671.

https://doi.org/10.1182/blood.V108.11.1671.1671

Published: 2006

Journal Articles

Standardized 4 Color Flow Cytometric Minimal Residual Disease Detection Failed To Overcome Regeneration Problems but Identifies Early Blast Clearence Predictive of Molecular Remission after Induction in Childhood B Lineage Leukemia.

Ester Mejstrikova, MD, Eva Fronkova, MD, PhD, Drago Batinic, MD, PhD, Klara Dubravcic, Flora Kiss, MD, Janos Kappelmayer, MD, PhD, Drorit Luria, PhD, Alice Suk Hang Cheng, BSc, PhD, Batia Stark, MD, PhD, Margaret Ng, MD, PhD, Yonna Leung, Bsc, Shai Izraeli, MD, PhD, Martina Vaskova, MSc, Katerina Zdrahalova, MD, Jan Trka, MD, PhD, Jan Stary, MD, PhD, Tomas Kalina, MD, PhD, Ondrej Hrusak, MD, PhD

Blood (2006) 108 (11): 1842.

https://doi.org/10.1182/blood.V108.11.1842.1842

Published: 2006

Journal Articles

Detectable Minimal Residual Disease before Haematopoietic Stem Cell Transplantation Predicts Extremely Poor Prognosis in Children with Acute Lymphoblastic Leukaemia.

Katerina Muzikova, Bc, Eva Fronkova, MD, Lucie Sramkova, MD, Leona Reznickova, Renata Formankova, MD, PhD, Petr Sedlacek, MD, CSc, Jan Stary, MD, DrSc, Jan Trka, MD, PhD

Blood (2005) 106 (11): 2037.

https://doi.org/10.1182/blood.V106.11.2037.2037

Published: 2005

Journal Articles

Minimal Residual Disease Detection Identifies Differences between the Risk Groups Defined by the ALL IC-BFM 2002 and the ALL-BFM 2000 Protocols.

Eva Fronkova, MD, Leona Reznickova, Katerina Muzikova, Ester Mejstrikova, MD, Ondrej Hrusak, MD, PhD, Martin Schrappe, MD, PhD, Jan Stary, MD, PhD, Jan Trka, MD, PhD

Blood (2004) 104 (11): 1085.

https://doi.org/10.1182/blood.V104.11.1085.1085

Published: 2004

Journal Articles

Detection of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia by 4color Cytometry in International Multicenter Trial Minimini.

Ester Mejstrikova, MD, Drago Batinic, MD, PhD, Dubravcic Klara, Margareth Ng, MD, PhD, Yonna Leung, MSc, Janos Kappelmayer, MD, PhD, Drorit Luria, PhD, Shai Izraeli, MD, PhD, Tomas Kalina, MD, Martina Vaskova, MSc, Eva Fronkova, MD, Jan Stary, MD, DSc, Jan Trka, MD, PhD, Ondrej Hrusak, MD, PhD

Blood (2004) 104 (11): 1092.

https://doi.org/10.1182/blood.V104.11.1092.1092

Published: 2004

NARROW

Deep Immunoprofiling By Flow Cytometry and NGS Reveals Distinct T Cell Profile in Pediatric Hepatitis-Associated Aplastic Anemia

Co-Targeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Refractory Mantle Cell Lymphoma with Complex Karyotype Changes

B Cell Precursor Lymphoblastic Leukemia Patients with Good Treatment Response Have Low Levels of Erythroid Precursors

Switching Towards Monocytic Lineage and Discordancy between Flow Cytometric and PCR Minimal Residual Disease Results Is a Hallmark Feature of DUX4 Rearranged B-Cell Precursor Acute Lymphoblastic Leukemia

Folate-Dependent Normocytic Anemia Caused By a Hypomorphic Mutation in SLC19A1 gene

Observational Study Alternating R-CHOP21 and R-Cytarabine (3+3 Cycles) for Patients with Newly Diagnosed Mantle Cell Lymphoma Not Eligible for High-Dose Therapy: A Czech Lymphoma Study Group Trial Preliminary Results

Next Generation Amplicon Sequencing of Immunoglobulin Heavy Chain Gene Rearrangaments for Minimal Residual Disease (MRD) Stratification in Childhood Acute Lymphoblastic Leukemia (ALL): A Comparison with Classical qPCR-Based Technique

Potential Involvement of Physiological TCR Gamma Delta Clones in Immune Surveillance of Preleukemic Cells

Refinement of IKZF1 Genomic Status in Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Prediction of Relapse By microRNA Expression in Pediatric B-Lineage Acute Lymphoblastic Leukemia

Prognostic Value of Rare IKZF1 deletions in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia: An International Collaborative Study

Prognostic Impact of Ikaros (IKZF1) Gene Alterations In Childhood ALL Treated with ALL IC-BFM 2002 Protocol: A Comparison of Gene Expression and Genomic-Based Methods.

B Precursor ALL Subset with Aberrant CD2 Expression and a Specific Predisposition to Early Monocytic Transdifferentiation

Relative Expression of Ikaros Isoforms Has a Prognostic Impact in Phildelphia-Negative Childhood Acute Lymphoblastic Leukemia.

Prognostic Impact of Peripheral Blood Involvement during Early Time Points of Childhood ALL Treatment.

CD44 and CD27 Expression Delineates Stages of B Precursor Development Reflecting Recombination Status and Propensity to Leukemic Transformation.

Standardized 4 Color Flow Cytometric Minimal Residual Disease Detection Failed To Overcome Regeneration Problems but Identifies Early Blast Clearence Predictive of Molecular Remission after Induction in Childhood B Lineage Leukemia.

Detectable Minimal Residual Disease before Haematopoietic Stem Cell Transplantation Predicts Extremely Poor Prognosis in Children with Acute Lymphoblastic Leukaemia.

Minimal Residual Disease Detection Identifies Differences between the Risk Groups Defined by the ALL IC-BFM 2002 and the ALL-BFM 2000 Protocols.

Detection of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia by 4color Cytometry in International Multicenter Trial Minimini.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only